INS and obesity disorder: The reduced tyrosine phosphorylation and increased serine/threonine phosphorylation of IRS-1 due to diabetes or obesity have mostly been considered to be negative regulators of IRS-1 function and are widely regarded as critical players in inhibiting insulin signaling [6,7].